Jae-Kyu Jung

USPTO Granted Patents = 15 (Patent Applications = 5)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 46(Granted Patents)

Company Filing History:

15 out of 216

Arena Pharmaceuticals, Inc.

Merck Sharp + Dohme Corp.

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109219 - Cannabinoid receptor modulators (2024-10-08),

2. 11771695 - Cannabinoid receptor modulators (2023-10-03),

3. 11746091 - Cannabinoid receptor modulators (2023-09-05),

4. 11214548 - Cannabinoid receptor modulators (2022-01-04),

5. 10632134 - Cannabinoid receptor modulators (2020-04-28),

6. 9944606 - Cannabinoid receptor modulators (2018-04-17),

7. 9867822 - Cannabinoid receptor modulators (2018-01-16),

8. 9597340 - Cannabinoid receptor modulators (2017-03-21),

9. 9492447 - Cannabinoid receptor modulators (2016-11-15),

10. 8778950 - Cannabinoid receptor modulators (2014-07-15),

11. 8637555 - Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof (2014-01-28),

12. 8507473 - [object Object] (2013-08-13),

13. 7803837 - 4-oxo-4,5-dihydro-furan-2-carboxylic acid derivatives and methods of treatment of metabolic-related disorders thereof (2010-09-28),

14. 7612106 - Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof (2009-11-03),

15. 7241792 - Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof (2007-07-10),

Title: Jae-Kyu Jung: Innovator in Cannabinoid Research

Introduction

Jae-Kyu Jung is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cannabinoid research, particularly in the development of compounds that modulate cannabinoid receptors. With a total of 15 patents to his name, Jung's work is paving the way for innovative treatments in various medical applications.

Latest Patents

Among his latest patents, Jung has developed cannabinoid receptor modulators that provide methods useful in the treatment of cancer. These methods involve administering a compound of Formula Ia and pharmaceutical compositions that modulate the activity of the cannabinoid CB receptor. Additionally, he has created cannabinoid receptor modulators aimed at treating pain, utilizing similar compounds and methodologies.

Career Highlights

Jae-Kyu Jung has worked with notable companies in the pharmaceutical industry, including Arena Pharmaceuticals, Inc. and Merck & Co., Inc. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in cannabinoid therapies.

Collaborations

Jung has collaborated with esteemed colleagues such as Robert M. Jones and Sangdon Han. These partnerships have further enhanced his research and development efforts in cannabinoid receptor modulation.

Conclusion

Jae-Kyu Jung's innovative work in cannabinoid research is making a significant impact in the medical field. His patents and collaborations reflect his dedication to advancing treatment options for cancer and pain management.

This text is generated by artificial intelligence and may not be accurate.